Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

VEGF-C as a putative therapeutic target in cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Application of cell-free DNA for genomic tumor profiling: a feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalOncotarget
Volume10
Issue number40
Pages (from-to)3988-3990
Number of pages3
ISSN1949-2553
DOIs
Publication statusPublished - 18 Jun 2019

ID: 59085955